OrphanDrug
OrphanDrug
Pharma Knowledge Base

hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome

MeSH: C563324ORPHA: 71290

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

Familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) is characterised by moderate thrombocytopenia, abnormal platelet function and the propensity to develop myeloid malignancies, in particular AML

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

MeSH Code

C563324

Orphanet Code

ORPHA:71290
hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome
MeSHC563324
OrphanetORPHA:71290
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO